| If you have just been diagnosed with diabetes — or love someone who has — this article is for you. Type 1 and Type 2 diabetes share a name and a number (high blood sugar), but they are completely different diseases with different causes, different treatments, and different long-term paths. Understanding the distinction does not just satisfy curiosity — it shapes every decision you make about food, medication, and daily life. |
STEP 1 | Where did your problem start?
The one thing both types have in common
Before we separate them, they both share on foundation. Both Type 1 and Type 2 diabetes involve insulin — a hormone produced by the pancreas that acts like a key, unlocking your cells so glucose (sugar from food) can enter and be used for energy. When insulin is absent or ineffective, glucose cannot get into cells. Instead, it builds up in the bloodstream, causing hyperglycaemia — the hallmark of both types of diabetes.
Type 1 diabetes is an autoimmune disease.
Your immune system is designed to fight foreign invaders — viruses, bacteria, anything that should not be there. In Type 1 diabetes, the immune system makes a catastrophic mistake: it attacks and destroys the beta cells in the pancreas — the only cells in your body capable of producing insulin.
Once those cells are gone, the pancreas produces little to no insulin at all. There is no longer a key to unlock the cells. This is not something you caused. It is not linked to diet, inactivity, or body weight. Research points to a combination of genetic susceptibility and environmental triggers — possibly a viral infection that confused the immune system into attacking the body’s own tissue.³
Type 2 Diabetes — When Cells Stop Listening to Insulin
Type 2 diabetes is a metabolic disease driven by insulin resistance. In Type 2, the pancreas still produces insulin — sometimes in very large amounts initially. The problem is that the body’s cells stop responding properly to insulin’s signal.
Think of it like a lock that has become jammed: the key is there, but it no longer turns the lock effectively. To compensate, the pancreas works overtime, pumping out more and more insulin. Over years, this overworked pancreas begins to burn out, and insulin production also starts to decline. The result: blood sugar stays high.⁴
Side-by-Side Comparison
| TYPE 1 DIABETES | TYPE 2 DIABETES | |
| What causes it? | Autoimmune — immune system destroys insulin-producing cells | Insulin resistance — cells stop responding to insulin |
| Who typically gets it? | Any age; most often children, teens, young adults | Adults 45+; increasingly younger people and children |
| Does the pancreas make insulin? | Little to none | Yes, initially (may decline over time) |
| Does lifestyle cause it? | No. Not linked to diet or weight | Partly yes. Lifestyle is a major contributing factor |
| Can it be prevented? | No known prevention currently | Often preventable with diet, exercise, and weight management |
| Can it be reversed? | No | Sometimes — remission is possible with significant weight loss |
| Main treatment? | Insulin therapy (always required) | Lifestyle change, oral medication, sometimes insulin |
| How is it managed daily? | Continuous blood glucose monitoring, insulin dosing | Diet, exercise, medication, blood glucose monitoring |
| What happens without treatment? | Diabetic ketoacidosis (DKA) — life-threatening within days | Gradual organ damage over years — heart, kidneys, eyes, nerves |
STEP 2 | What does this break inside your body?
What happens without treatment
For Type 1: Without insulin replacement, the body begins breaking down fat at a dangerous rate, producing toxic by-products called ketones. This condition — diabetic ketoacidosis (DKA) — can become life-threatening within days. This is why insulin therapy for Type 1 is not optional: it is immediately necessary for survival.
For Type 2: The danger is slower but no less serious. Persistently high blood sugar causes progressive damage to blood vessels and nerves throughout the body. Unlike Type 1, there is no acute emergency in the early stages — which is exactly why so many people with Type 2 go undiagnosed for years, accumulating damage silently.
Recognising the Symptoms
Because the origins differ, so does the way each type presents. Type 1 tends to arrive suddenly and dramatically; Type 2 often creeps in so gradually that symptoms are dismissed as tiredness or ageing.
| Symptom | Type 1 Onset | Type 2 Onset |
| Frequent urination | Sudden and intense | Gradual, often ignored |
| Extreme thirst | Rapid onset | May be mild or absent early on |
| Unexplained weight loss | Common and pronounced | Less common |
| Fatigue | Severe | Often dismissed as ‘normal tiredness’ |
| Blurred vision | Can occur rapidly | Often develops slowly |
| Slow-healing cuts/wounds | Less characteristic | Very common |
| Tingling / numbness (hands/feet) | Less common initially | Common — indicates nerve damage |
| Time from onset to diagnosis | Days to weeks | Often years — many are undiagnosed |
Long-term impact: what both types share
Despite their different origins, both Type 1 and Type 2 carry the same long-term risks when blood glucose is poorly managed. This is the part of the diagnosis that motivates daily management — not fear, but informed understanding of what consistent control prevents.
- Cardiovascular disease — heart attacks and stroke are 2–3x more likely in people with diabetes
- Diabetic retinopathy — damage to the retina; the leading cause of new blindness in working-age adults
- Diabetic nephropathy — kidney disease that can progress to dialysis
- Peripheral neuropathy — nerve damage causing pain, numbness, and ulcers in the feet and hands
STEP 3 | What changes now, and who is responsible?
How management differs — because the cause differs
Because the origin is different, the fix is different. Type 1 management is about replacing what the immune system destroyed. Type 2 management is about restoring the sensitivity that was lost — and in some cases, reversing the disease entirely.
| TYPE 1: Treatment Pillars | TYPE 2: Treatment Pillars |
| Insulin therapy — always required; via injections or pump. Continuous glucose monitoring (CGM) — tracks trends in real time. Carbohydrate counting — matching insulin dose to food intake Regular check-ups — eyes, kidneys, feet, cardiovascular system. Exercise planning — managing glucose fluctuations during activity | Dietary change — reducing ultra-processed foods, refined carbohydrates. Regular physical activity — improves insulin sensitivity immediately. Weight management — 5–10% body weight loss produces meaningful improvements. Oral medications — metformin is usually first-line; GLP-1 agonists are increasingly used. Insulin therapy — may be needed as the disease progresses |
For Type 2: the levers you can pull
Unlike Type 1, Type 2 has modifiable risk factors — things you can act on. This is not a list of blame. It is a list of leverage.
- Excess body fat, particularly around the abdomen, is the strongest modifiable risk factor
- Physical inactivity reduces insulin sensitivity over time — movement restores it
- Dietary patterns high in refined carbohydrates and ultra-processed foods accelerate progression
- Family history and age increase risk but do not make Type 2 inevitable
- Ethnicity matters: South Asian, African, and Hispanic/Latino populations face significantly higher risk at lower BMI thresholds than white European populations — screening should happen earlier
Remission is possible. Research shows that significant weight loss — typically 10–15kg — can return blood glucose to non-diabetic levels in many people with Type 2, particularly within the first few years of diagnosis.
Section 8: Questions to Ask Your Doctor
Walking into a medical appointment prepared makes an enormous difference. Here are the most important questions depending on your type.
| If you have (or suspect) Type 1: | If you have (or suspect) Type 2: |
| How do I know my insulin dose is right for my meals and activity? What should I do if my blood sugar goes very low (hypoglycaemia)? Am I a candidate for a continuous glucose monitor or insulin pump? How often should I be screened for complications (eyes, kidneys, feet)? Are there clinical trials I should know about? Should my close relatives be screened for autoimmune markers? | What is my A1C target, and how do I track progress? Is remission possible in my case, and what would it take? Which lifestyle change will have the biggest impact first? Should I be working with a registered dietitian? What does it mean if I eventually need insulin? What are my heart and kidney risks, and how do we monitor them? |
Related Post: How do I Lower my A1c naturally
The Bottom Line
Whether you have Type 1, Type 2, or are supporting someone who does — knowledge is your most powerful tool. The diagnosis itself is not the end of the conversation. It’s the beginning of a new relationship with your body, one that is informed by science and guided by compassion.
At Nourishfix, we believe that confused patients become passive patients. Informed patients become empowered ones. That’s why every resource we create is designed to teach you the why — so you can own the how.
Explore our Diabetes Program now and get better equiped to manage your blood sugar.
Scientific References
References
1. Laugesen, E., Østergaard, J.A., & Leslie, R.D. (2015). Latent autoimmune diabetes of the adult: current knowledge and uncertainty. Diabetic Medicine, 32(7), 843–852. https://doi.org/10.1111/dme.12700
2. International Diabetes Federation (2025). IDF Diabetes Atlas, 11th Edition. Brussels: International Diabetes Federation. https://diabetesatlas.org
3. Atkinson, M.A., Eisenbarth, G.S., & Michels, A.W. (2014). Type 1 diabetes. The Lancet, 383(9911), 69–82. https://doi.org/10.1016/S0140-6736(13)60591-7
4. DeFronzo, R.A., Ferrannini, E., Groop, L., Henry, R.R., Herman, W.H., Holst, J.J., … & Weiss, R. (2015). Type 2 diabetes mellitus. Nature Reviews Disease Primers, 1, 15019. https://doi.org/10.1038/nrdp.2015.19
5. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A., & Nathan, D.M. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393–403. https://doi.org/10.1056/NEJMoa012512
6. Ntuk, U.E., Gill, J.M.R., Mackay, D.F., Sattar, N., & Pell, J.P. (2014). Ethnic-specific obesity cutoffs for diabetes risk: cross-sectional study of 490,288 UK biobank participants. Diabetes Care, 37(9), 2500–2507. https://doi.org/10.2337/dc13-2966
7. American Diabetes Association (2024). Standards of Care in Diabetes — 2024. Diabetes Care, 47(Supplement 1). https://doi.org/10.2337/dc24-Sint
8. Lean, M.E.J., Leslie, W.S., Barnes, A.C., Brosnahan, N., Thom, G., McCombie, L., … & Taylor, R. (2018). Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet, 391(10120), 541–551. https://doi.org/10.1016/S0140-6736(17)33102-1
9. Donald S. Fong, Lloyd Aiello, Thomas W. Gardner, George L. King, George Blankenship, Jerry D. Cavallerano, Fredrick L. Ferris, Ronald Klein, for the American Diabetes Association; Retinopathy in Diabetes. Diabetes Care 1 January 2004; 27 (suppl_1): s84–s87. https://doi.org/10.2337/diacare.27.2007.S84
10. Emerging Risk Factors Collaboration, Sarwar N, Gao P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-2222. doi:10.1016/S0140-6736(10)60484-9
